Determination of the susceptibility in vitro of 54 isolates of Mycobacterium fortuitum against three fluoroquinolones using two methods.
The in vitro susceptibility to ofloxacin, norfloxacin and ciprofloxacin or 54 Mycobacterium fortuitum isolates originating from clinical samples (7) of patients attending the Hospital Universitario de Canarias and Hospital del Tórax, and from environmental (47) sources, were determined. For this, two methods were used: dilution in agar with Middlebrook 7H10 Agar as a base medium culture, and broth microdilution, with Mueller-Hinton Broth without supplement. The different isolates under study revealed a uniform susceptibility by both methods against ciprofloxacin. 100% inhibition was obtained from a Minimum Inhibitory Concentration (MIC) of 0.25 microgram/ml, and 2 micrograms/ml of ciprofloxacin, for broth microdilution and dilution in agar, respectively. For ofloxacin and norfloxacin, all the isolates were inhibited at an MIC of 0.5 microgram/ml, by the broth microdilution method, which contrasted sharply with an MIC of 32 micrograms/ml, in the case of dilution in agar. In this study, we have observed the existence of differences in the in vitro susceptibility of the isolates of M. fortuitum against the three fluoroquinolones assayed, mainly for ofloxacin and norfloxacin, by both methods. We, therefore, consider it necessary to establish a standardized, reproducible assay method, for the study of sensitivity to atypical mycobacteria.
Hernández
A M
AM
Chair of Preventive Medicine and Public Health, University of La Laguna, Spain.
Arias
A
A
Felipe
A
A
Alvarez
R
R
Sierra
A
A
D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects*; D009643:Norfloxacin / Q000494:pharmacology; D015242:Ofloxacin / Q000494:pharmacology
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin